Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of DTU and Kansas Nitrogen Assets

5 Nov 2020 07:00

RNS Number : 3102E
Zoetic International PLC
05 November 2020
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information for the purposes of Article 7 under the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

5 November 2020

 

Zoetic International plc

 

("Zoetic" or the "Company" or the "Group")

 

Update on Sale of DTU and Kansas Nitrogen Assets

 

Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD company, has reached a revised agreement to sell its 75 per cent interest in DT Ultravert ("DTU") to Path Investments plc ("Path"), as previously announced on 27 May, 8 July and 3 August 2020 (the "Transaction").

 

The primary revisions to the terms of the Transaction are as follows:

 

· The issue by Path to Zoetic of 30,000,000 new ordinary shares of 0.1 pence each in Path ("Path Shares") on the re-admission of Path Shares to the standard segment of the Official List maintained by the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange;

· Path will no longer issue 15,000,000 warrants to subscribe for Path Shares at any time from the first to the third anniversaries following completion at an exercise price of 0.75 pence per Path Share;

· Zoetic will no longer be selling its Kansas Nitrogen Assets to Path;

· Path will no longer pay a royalty to Zoetic on future revenues from DTU;

· Path will pay £42,000+VAT in cash to Zoetic on completion towards its professional and technical costs;

· Zoetic will no longer enter into an orderly market agreement in relation to any of its Path Shares; and

· The long-stop date for the Transaction will now be 31 December 2020.

 

In addition to the consideration elements set out above, Path will issue to Zoetic 15,000,000 warrants to subscribe for Path Shares at any time from the first to the third anniversaries following completion at an exercise price of 1.5 pence per Path Share.

 

The Company remains committed to its policy of exiting its legacy natural resources activities and the Directors will actively pursue alternative solutions in relation to the Kansas Nitrogen Assets.

 

Trevor Taylor, Co-CEO of Zoetic, commented, "We are committed to achieve the best deal possible for our shareholders, and we believe that the revised Transaction with Path is an example of this."

 

 

**ENDS**

Enquiries

 

Zoetic International plc c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPGQPGUPUPUC
Date   Source Headline
15th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 201610:15 amRNSDisposal of Warrants and Interest in Shares
15th Jun 20167:53 amRNSFinal Results
15th Jun 20167:50 amRNSHelios Two Transaction
14th Jun 201612:30 pmRNSIssue of Shares
10th Jun 20167:00 amRNSDT Ultravert Update
8th Jun 20167:00 amRNSAcquisition of Helium Licences in Montana
6th Jun 201611:34 amRNSInterest in Shares
31st May 20167:00 amRNSIssue of Shares
23rd May 20167:00 amRNSLicence Agreement with Calfrac for DT UltraVert
20th May 20167:00 amRNSIncreases Uranium Acreage in Utah
20th May 20167:00 amRNSIssue of Shares
18th May 20169:00 amRNSFurther Acquisition of Licences in North Dakota
13th May 20167:00 amRNSIssue of Shares
9th May 20167:00 amRNSIssue of Shares
5th May 20164:40 pmRNSSecond Price Monitoring Extn
5th May 20164:35 pmRNSPrice Monitoring Extension
5th May 20167:00 amRNSIssue of Shares
28th Apr 20161:00 pmRNSIssue of Shares
27th Apr 201612:45 pmRNSResults of General Meeting
27th Apr 20167:00 amRNSShare Subscription Raises £519,093
25th Apr 20167:49 amRNSCorporate Update
1st Apr 20168:00 amRNSPublication of Circular and Notice of GM
30th Mar 20167:00 amRNSDoubles Utah Uranium Acreage
18th Mar 20162:45 pmRNSSigns Agreement for Potential Uranium Discovery
15th Mar 20167:00 amRNSIssue of Shares
11th Mar 20167:00 amRNSIssue of Shares
22nd Feb 20167:00 amRNSIssue of Shares
17th Feb 20167:00 amRNSIssue of Shares
11th Feb 201610:00 amRNSIssue of Shares
3rd Feb 20168:30 amRNSReadmission to Trading on London Stock Exchange
29th Jan 20167:00 amRNSPublication of Prospectus; Readmission; Placing
27th Nov 20157:00 amRNSInterim Results
16th Nov 20157:00 amRNSAcquires Leasehold Interest
25th Sep 20157:00 amRNSLicence Agreement with Schlumberger
19th Aug 20157:00 amRNSAppointment of Financial Adviser and Broker
30th Jun 20154:04 pmRNSHolding(s) in Company
25th Jun 20157:42 amRNSSuspension
25th Jun 20157:25 amRNSSuspension of Trading
29th May 20157:00 amRNSIssue of Equity
26th May 20157:01 amRNSCompletes Oilfield Technology Acquisition
12th May 20157:00 amRNSStrategy Update & Oilfield Technology Acquisition
25th Mar 20158:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.